Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic.

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic.
复制标题

DOI:
10.2337/dc20-2219
复制
发表时间:
2021-03
期刊:
影响因子:
16.2
通讯作者:
Pasquel FJ
Pasquel FJ
中科院分区:
医学1区
文献类型:
--
作者:
Agarwal S;Mathew J;Davis GM;Shephardson A;Levine A;Louard R;Urrutia A;Perez-Guzman C;Umpierrez GE;Peng L;Pasquel FJ

文献摘要

参考文献

被引文献

相似文献

实时连续血糖监测(rtCGM)对住院危重患者有希望;然而,需要真实世界的数据。我们对 Montefiore 医疗中心确诊的 2019 冠状病毒病 (COVID-19) 感染和血糖变异性的重症监护病房 (ICU) 患者进行了 Dexcom G6 CGM。我们使用护理点 (POC) 葡萄糖-CGM 配对对住院患者 CGM 准确性进行分析,并纳入患者进行分析,无论临床状态如何。我们纳入了 11 名 CGM 患者:8 名接受连续胰岛素输注 (CII),8 名接受血管升压药,8 名插管,4 名接受大剂量糖皮质激素,6 名接受肾脏替代治疗,2 名接受 anasarca。平均值的准确度为 12.58%,中位绝对相对差的准确度为 6.3%。 CGM 将 CII 患者的 POC 测试减少了约 60%。在危重病期间 rtCGM 的真实世界初步分析中,我们证明了 POC 血糖测试频率的早期可行性、相当高的准确性和有意义的降低。
Real-time continuous glucose monitoring (rtCGM) in critically ill hospitalized patients holds promise; however, real-world data are needed. We placed Dexcom G6 CGM on intensive care unit (ICU) patients at Montefiore Medical Center with confirmed coronavirus disease 2019 (COVID-19) infection and glycemic variability. We analyzed inpatient CGM accuracy using point-of-care (POC) glucose–CGM matched pairs and included patients for analysis regardless of clinical status. We included 11 patients with CGM: 8 on continuous insulin infusion (CII), 8 on vasopressors, 8 intubated, 4 on high-dose glucocorticoids, 6 on renal replacement therapy, and 2 with anasarca. Accuracy was 12.58% for mean and 6.3% for median absolute relative difference. CGM reduced POC testing by ∼60% for patients on CII. In this real-world preliminary analysis of rtCGM during critical illness, we demonstrate early feasibility, considerable accuracy, and meaningful reduction in the frequency of POC glucose testing.
DOI: 10.1177/1932296818812062
发表时间: 2019-05-01
影响因子: 5
作者:
Freckmann, Guido;Pleus, Stefan;Levy, Brian
通讯作者: Levy, Brian
DOI: 10.1089/dia.2020.0237
发表时间: 2020-07-15
影响因子: 5.4
作者:
Ushigome, Emi;Yamazaki, Masahiro;Fukui, Michiaki
通讯作者: Fukui, Michiaki
DOI: 10.2337/dc19-2073
发表时间: 2020-11
期刊: Diabetes care
影响因子: 16.2
作者:
Galindo RJ;Migdal AL;Davis GM;Urrutia MA;Albury B;Zambrano C;Vellanki P;Pasquel FJ;Fayfman M;Peng L;Umpierrez GE
通讯作者: Umpierrez GE
DOI: 10.1111/dom.14073
发表时间: 2020-06-13
影响因子: 5.8
作者:
Tripyla, Afroditi;Herzig, David;Bally, Lia
通讯作者: Bally, Lia
DOI: 10.1089/dia.2008.0138
发表时间: 2009-04-01
影响因子: 5.4
作者:
Clarke, William;Kovatchev, Boris
通讯作者: Kovatchev, Boris